Cambridge Investment Research Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.48M | Buy |
88,393
+4,130
| +5% | +$69.2K | ﹤0.01% | 1663 |
|
2025
Q1 | $1.3M | Buy |
84,263
+41,600
| +98% | +$639K | ﹤0.01% | 1657 |
|
2024
Q4 | $940K | Sell |
42,663
-10,873
| -20% | -$240K | ﹤0.01% | 1924 |
|
2024
Q3 | $965K | Buy |
53,536
+280
| +0.5% | +$5.05K | ﹤0.01% | 1878 |
|
2024
Q2 | $865K | Buy |
53,256
+6,601
| +14% | +$107K | ﹤0.01% | 1877 |
|
2024
Q1 | $658K | Buy |
46,655
+7,242
| +18% | +$102K | ﹤0.01% | 2030 |
|
2023
Q4 | $411K | Sell |
39,413
-3,502
| -8% | -$36.5K | ﹤0.01% | 2350 |
|
2023
Q3 | $438K | Buy |
42,915
+936
| +2% | +$9.55K | ﹤0.01% | 2197 |
|
2023
Q2 | $316K | Sell |
41,979
-10,084
| -19% | -$75.9K | ﹤0.01% | 2483 |
|
2023
Q1 | $461K | Sell |
52,063
-1,404
| -3% | -$12.4K | ﹤0.01% | 2153 |
|
2022
Q4 | $488K | Buy |
53,467
+4,959
| +10% | +$45.3K | ﹤0.01% | 2032 |
|
2022
Q3 | $391K | Buy |
48,508
+510
| +1% | +$4.11K | ﹤0.01% | 2141 |
|
2022
Q2 | $361K | Buy |
47,998
+990
| +2% | +$7.45K | ﹤0.01% | 2214 |
|
2022
Q1 | $441K | Sell |
47,008
-6,223
| -12% | -$58.4K | ﹤0.01% | 2213 |
|
2021
Q4 | $426K | Sell |
53,231
-4,011
| -7% | -$32.1K | ﹤0.01% | 2245 |
|
2021
Q3 | $558K | Buy |
57,242
+14,733
| +35% | +$144K | ﹤0.01% | 1960 |
|
2021
Q2 | $421K | Sell |
42,509
-6,914
| -14% | -$68.5K | ﹤0.01% | 2197 |
|
2021
Q1 | $570K | Buy |
49,423
+2,553
| +5% | +$29.4K | ﹤0.01% | 1812 |
|
2020
Q4 | $452K | Sell |
46,870
-7,320
| -14% | -$70.6K | ﹤0.01% | 1837 |
|
2020
Q3 | $488K | Sell |
54,190
-118,702
| -69% | -$1.07M | ﹤0.01% | 1616 |
|
2020
Q2 | $2.13M | Sell |
172,892
-131,930
| -43% | -$1.63M | 0.02% | 743 |
|
2020
Q1 | $2.74M | Buy |
304,822
+145,683
| +92% | +$1.31M | 0.03% | 543 |
|
2019
Q4 | $1.56M | Buy |
159,139
+127,245
| +399% | +$1.25M | 0.01% | 912 |
|
2019
Q3 | $219K | Buy |
31,894
+482
| +2% | +$3.31K | ﹤0.01% | 2056 |
|
2019
Q2 | $290K | Sell |
31,412
-1,065
| -3% | -$9.83K | ﹤0.01% | 1764 |
|
2019
Q1 | $509K | Buy |
32,477
+4,911
| +18% | +$77K | ﹤0.01% | 1468 |
|
2018
Q4 | $425K | Sell |
27,566
-2,151
| -7% | -$33.2K | ﹤0.01% | 1417 |
|
2018
Q3 | $640K | Sell |
29,717
-5,441
| -15% | -$117K | 0.01% | 1300 |
|
2018
Q2 | $855K | Sell |
35,158
-3,013
| -8% | -$73.3K | 0.01% | 1071 |
|
2018
Q1 | $652K | Sell |
38,171
-7,812
| -17% | -$133K | 0.01% | 1189 |
|
2017
Q4 | $871K | Buy |
45,983
+6,642
| +17% | +$126K | 0.01% | 972 |
|
2017
Q3 | $692K | Buy |
39,341
+3,135
| +9% | +$55.1K | 0.01% | 1032 |
|
2017
Q2 | $1.2M | Buy |
36,206
+5,381
| +17% | +$179K | 0.02% | 717 |
|
2017
Q1 | $989K | Buy |
30,825
+4,564
| +17% | +$146K | 0.02% | 731 |
|
2016
Q4 | $952K | Buy |
26,261
+173
| +0.7% | +$6.27K | 0.02% | 698 |
|
2016
Q3 | $1.2M | Buy |
26,088
+1,861
| +8% | +$85.6K | 0.02% | 603 |
|
2016
Q2 | $1.22M | Sell |
24,227
-1,075
| -4% | -$54K | 0.03% | 528 |
|
2016
Q1 | $1.35M | Sell |
25,302
-563
| -2% | -$30.1K | 0.03% | 457 |
|
2015
Q4 | $1.7M | Buy |
25,865
+1,411
| +6% | +$92.6K | 0.04% | 392 |
|
2015
Q3 | $1.38M | Buy |
24,454
+966
| +4% | +$54.6K | 0.04% | 393 |
|
2015
Q2 | $1.39M | Buy |
23,488
+1,769
| +8% | +$105K | 0.04% | 408 |
|
2015
Q1 | $1.35M | Sell |
21,719
-48
| -0.2% | -$2.99K | 0.04% | 412 |
|
2014
Q4 | $1.25M | Sell |
21,767
-883
| -4% | -$50.8K | 0.04% | 418 |
|
2014
Q3 | $1.22M | Buy |
22,650
+1,763
| +8% | +$94.7K | 0.04% | 449 |
|
2014
Q2 | $1.1M | Buy |
20,887
+5,313
| +34% | +$279K | 0.04% | 430 |
|
2014
Q1 | $823K | Buy |
15,574
+472
| +3% | +$24.9K | 0.03% | 490 |
|
2013
Q4 | $605K | Buy |
15,102
+358
| +2% | +$14.3K | 0.02% | 581 |
|
2013
Q3 | $557K | Sell |
14,744
-1,853
| -11% | -$70K | 0.02% | 579 |
|
2013
Q2 | $651K | Buy |
+16,597
| New | +$651K | 0.03% | 442 |
|